- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 22 - Antiplatelet Agents Explored
Because of recently updated recommendations by the American College of Cardiology Foundation and American Heart Association about how to treat patients with cardiovascular disorders with antiplatelet therapy, Michael Weber, MD, discusses his personal recommendations.
Kenneth L. Schaecher, MD, FACP, CPC, briefly explains both the clinical and economic outcomes demonstrated through treatment with these agents, and because a large number of antiplatelet drugs are developing, David Calabrese, RPh, MHP, discusses how newer agents address treatment gaps and have better economic value when compared to older agents.
Although Dr Schaecher agrees with the potential of these new drugs, he concludes that there are still many unanswered questions about the ability of these agents to treat patients at risk for developing cardiometabolic events.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
